Impact of Different Levels of iPTH on All-Cause Mortality in Dialysis Patients with Secondary Hyperparathyroidism after Parathyroidectomy

Abstract EN

Background.

Secondary hyperparathyroidism (SHPT) usually required parathyroidectomy (PTX) when drugs treatment is invalid.

Analysis was done on the impact of different intact parathyroid hormone (iPTH) after the PTX on all-cause mortality.

Methods.

An open, retrospective, multicenter cohort design was conducted.

The sample included 525 dialysis patients with SHPT who had undergone PTX.

Results.

404 patients conformed to the standard, with 36 (8.91%) deaths during the 11 years of follow-up.

One week postoperatively, different levels of serum iPTH were divided into four groups: A: ≤20 pg/mL; B: 21–150 pg/mL; C: 151–600 pg/mL; and D: >600 pg/mL.

All-cause mortality in groups with different iPTH levels appeared as follows: A (8.29%), B (3.54%), C (10.91%), and D (29.03%).

The all-cause mortality of B was the lowest, with D the highest.

We used group A as reference (hazard ratio (HR) = 1) compared with the other groups, and HRs on groups B, C, and D appeared as 0.57, 1.43, and 3.45, respectively.

Conclusion.

The all-cause mortality was associated with different levels of iPTH after the PTX.

We found that iPTH > 600 pg/mL appeared as a factor which increased the risk of all-cause mortality.

When iPTH levels were positively and effectively reducing, the risk of all-cause mortality also decreased.

The most appropriate level of postoperative iPTH seemed to be 21–150 pg/mL.